Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Delstrigo for the Treatment of HIV-1 Infection

Drug Name

Delstrigo™ (doravirine / lamivudine / tenofovir disoproxil fumarate)

Developer

Merck

Therapy Class

Antiretroviral

Product Description

Combination of a non-nucleoside reverse transcriptase inhibitor and two nucleoside analogue reverse transcriptase inhibitors

Current Indication

HIV-1 infection

Market Sector

Infectious diseases

Development Status

Approved in the US, Canada, and Europe
Expand
Close
Close
Close

Go Top